Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Expert Review of Neurotherapeutics
|
March 10, 2016
Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders
Michael Tolmasov, Ruth Djaldetti, Nirit Lev, et al.
European Journal of Internal Medicine
|
February 26, 2019
Iron supplementation for restless legs syndrome - A systematic review and meta-analysis
Tomer Avni, Shelley Reich, Nirit Lev, et al.
Cerebellum (London, England)
|
June 10, 2020
Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
Roy Zaltzman, Zohar Elyoseph, Nirit Lev, et al.
Clinical Neuropharmacology
|
September 19, 2013
Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease
Aeyal Raz, Nirit Lev, Sharon Orbach-Zinger, et al.
Frontiers in Neurology
|
February 11, 2026
Migraine epidemiology, comorbidities and therapeutic landscape: a national population-based study
Nirit Lev, Lihie Sheffer, Ido Peles, et al.
Journal of Molecular Neuroscience : MN
|
August 21, 2008
DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS
Nirit Lev, Debby Ickowicz, Yael Barhum, et al.
Plos One
|
March 31, 2015
DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS
Nirit Lev, Yael Barhum, Itay Lotan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
December 24, 2004
Progressive multifocal leukoencephalopathy in transplant recipients
David Shitrit, Nirit Lev, Ariella Bar-Gil-Shitrit, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 1, 2008
DJ-1 protects against dopamine toxicity
Nirit Lev, Debby Ickowicz, Yael Barhum, et al.
Acta Haematologica
|
January 31, 2022
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
Dmitri Guz, Anat Gafter-Gvili, Nirit Lev, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Expert Review of Neurotherapeutics
|
March 10, 2016
Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders
Michael Tolmasov, Ruth Djaldetti, Nirit Lev, et al.
European Journal of Internal Medicine
|
February 26, 2019
Iron supplementation for restless legs syndrome - A systematic review and meta-analysis
Tomer Avni, Shelley Reich, Nirit Lev, et al.
Cerebellum (London, England)
|
June 10, 2020
Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
Roy Zaltzman, Zohar Elyoseph, Nirit Lev, et al.
Clinical Neuropharmacology
|
September 19, 2013
Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease
Aeyal Raz, Nirit Lev, Sharon Orbach-Zinger, et al.
Frontiers in Neurology
|
February 11, 2026
Migraine epidemiology, comorbidities and therapeutic landscape: a national population-based study
Nirit Lev, Lihie Sheffer, Ido Peles, et al.
Journal of Molecular Neuroscience : MN
|
August 21, 2008
DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS
Nirit Lev, Debby Ickowicz, Yael Barhum, et al.
Plos One
|
March 31, 2015
DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS
Nirit Lev, Yael Barhum, Itay Lotan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
December 24, 2004
Progressive multifocal leukoencephalopathy in transplant recipients
David Shitrit, Nirit Lev, Ariella Bar-Gil-Shitrit, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 1, 2008
DJ-1 protects against dopamine toxicity
Nirit Lev, Debby Ickowicz, Yael Barhum, et al.
Acta Haematologica
|
January 31, 2022
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
Dmitri Guz, Anat Gafter-Gvili, Nirit Lev, et al.
Page
of 4